Today

Agents

Chat

Arena

Discover

More

App

Iovance Biotherapeutics Q2 Revenue USD 99.313 Million - IOVA News | Rallies

Iovance Biotherapeutics Q2 Revenue USD 99.313 Million

IOVA•2026-08-06

Q2 financial results

Aug 06 (Reuters) - Iovance Biotherapeutics Q2 net income USD -47.315 million vs. IBES estimate USD -57.6 million.

Q2 operating income USD -51.905 million vs. IBES estimate USD -59.7 million
Q2 pretax profit USD -48.688 million vs. IBES estimate USD -59.8 million

Related News

Zillow: US home sales rise 7% in July as pending listings slump 7.7% from June

ZG•2026-08-06

Ralph Lauren Q1 FY27 EPS rises 22% to $4.28; revenue increases 14% to $2 billion

RL•2026-08-06

Lazard names Brian McCabe head of North America energy in Power, Energy and Infrastructure group

LAZ

•

2026-08-06

Zoetis cuts annual forecasts as pet healthcare demand slows

ZTS•2026-08-06

Koppers Q2 FY26 turns to loss of $147.5 million; net sales rise 3% to $520.1 million

KOP•2026-08-06